The answer is <span>Patients with hyperkalemia.
</span>Potassium-sparing diuretics are diuretic drugs that inhibit the secretion of potassium into the urine. Because of that, they raise potassium levels in the body.
People with hyperkalemia (higher amounts of potassium) can't take<span> potassium-sparing diuretic because it will make potassium levels even higher, making it a </span>risks for fatal arrhythmias.
<span>The patient's PaO2 and SpO2 indicate inadequate oxygenation. Complications associated with these findings include tissue hypoxia and cardiac arrhythmia. Atelectasis, pleural effusion, and pulmonary edema are not complications associated with these data.</span>
Answer:
The answer here would be D, proteins.
Explanation:
Transcription forms RNA, while translation forms a polypeptide amino acid chain. Through a long process the polypeptide amino acid chain will eventually synthesize a protein.
